M. Destefanis

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

S. Barni, R. Labianca, G. Luporini, 2005, Tumori.

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.

L. Dogliotti, F. Deltetto, M. Tampellini, 1997, British Journal of Cancer.

Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.

A. Venturino, I. Sarotto, V. Fontana, 1999, Anticancer research.

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.

P. Zola, A. Bottini, L. Dogliotti, 1997, Anticancer research.

Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?

M. Pestrin, A. Di Leo, L. Biganzoli, 2009, Breast.